Načítá se...
BRD4 and Cancer: going beyond transcriptional regulation
BRD4, member of the Bromodomain and Extraterminal (BET) protein family, is largely acknowledged in cancer for its role in super-enhancers (SEs) organization and oncogenes expression regulation. Inhibition of BRD4 shortcuts the communication between SEs and target promoters with a subsequent cell-spe...
Uloženo v:
| Vydáno v: | Mol Cancer |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6251205/ https://ncbi.nlm.nih.gov/pubmed/30466442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-018-0915-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|